Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the MyChoice ® CDx ...

Closed Private Placement Financing of up to $30 Million HUNTSVILLE, March 25, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...

MOUNT PLEASANT, SC / ACCESS Newswire / March 19, 2026 / Deep Sea Rare Minerals, Inc. ("DSRM" or the "Company") today announced completion of a pre-front-end engineering and design ("pre-FEED") study, ...

The Senior Staff Association of Nigeria Polytechnics, Moshood Abiola Polytechnic, Abeokuta, on Tuesday called on Governor Dapo Abiodun to provide special intervention funds to address the deplorable ...

The "Environmental Testing Equipment Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global Environmental ...

SER-252 Phase 1b Trial Initiated- Closed Private Placement Financing of up to $30 Million HUNTSVILLE, March 25, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the ...

First tranche of $15 million expected to close on March 20, 2026; second tranche of up to $15 million available, for up to ...

Detailed price information for Dianthus Therapeutics Inc (DNTH-Q) from The Globe and Mail including charting and trades.

In the early days of the fall 2025 semester, the California State University officially partnered with Educational Testing Services (ETS) and their program FutureNav Compass – FutureNav Compass is an ...